Skip to search formSkip to main contentSkip to account menu

DB 289

Known as: 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, DB-289, DB289 cpd 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

pafuramidine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
Review
2003
Review
2003
DB-289 Immtech International.
  • C. Yeates
  • IDrugs : the investigational drugs journal
  • 2003
  • Corpus ID: 40628056
DB-289, an oral diamidoxime prodrug of DB-75 from the University of North Carolina, Georgia State University, Auburn University… 
2002
2002
Characterizing the fragmentation of 2,5-bis (4-amidinophenyl)furan-bis-O-methylamidoxime and selected metabolites using ion trap mass spectrometry.
A novel prodrug [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime (DB289)] of the promising antimicrobial agent, 2,5-bis(4… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)